DCI: A Community Based Pre-cardiac Surgery Diabetes Care Project
NCT ID: NCT01824277
Last Updated: 2018-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2013-10-31
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this project is to determine the feasibility and effectiveness of a comprehensive community-based pre-operative diabetes optimization program for patients awaiting elective cardiac surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Optimization of Diabetic Patients
NCT06589466
Long-term Mortality in Diabetics Undergoing Major Surgery
NCT00286572
Hemoglobin A1c and Immediate Postsurgical Complications Diabetes Type 2
NCT01403961
Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes
NCT05431296
Impact of Prediabetes on Acute Coronary Syndrome
NCT05102851
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Group 1 - Standard Pre-operative Diabetes Care
No interventions assigned to this group
Group 2
Group 2 - Structured Pre-operative Diabetes Optimization
Structured Pre-operative Diabetes Optimization
Patients will receive structured pre-operative diabetes optimization while they wait for surgery. Patients will be referred to the Youville Diabetes Center where they will undergo preoperative optimization of their diabetes management. This will include in-depth diabetes education and instruction pertaining to lifestyle modification (blood glucose monitoring, nutrition, and physical activity) to improve glycemic control. Pharmacologic therapy will be reviewed by the Youville Diabetes Center certified diabetes nurse educators.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Structured Pre-operative Diabetes Optimization
Patients will receive structured pre-operative diabetes optimization while they wait for surgery. Patients will be referred to the Youville Diabetes Center where they will undergo preoperative optimization of their diabetes management. This will include in-depth diabetes education and instruction pertaining to lifestyle modification (blood glucose monitoring, nutrition, and physical activity) to improve glycemic control. Pharmacologic therapy will be reviewed by the Youville Diabetes Center certified diabetes nurse educators.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18
* Able to provide informed consent
* A1C\>7%
* Placed on the waiting list for elective cardiac surgery in Manitoba
Exclusion Criteria
* Age \< 18
* Unable to provide informed consent
* A1C\<7%
* Undergoing emergent cardiac surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Rakesh C. Arora
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Rakesh C. Arora
Medical Director, Intensive Care Cardiac Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rakesh C Arora, MD
Role: PRINCIPAL_INVESTIGATOR
University of Manitoba
Sora Ludwig, MD
Role: PRINCIPAL_INVESTIGATOR
University of Manitoba
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Youville Diabetes Center
Winnipeg, Manitoba, Canada
I.H. AsperInstitute, St. Boniface General Hospital
Winnipeg, Manitoba, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GRT2012-53
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.